GMO Product Platform, Inc. (TYO:3695)
Japan · Delayed Price · Currency is JPY 1,627.00
-23.00 (-1.39%)
Sep 9, 2026, 3:30 PM JST
GMO Product Platform Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,370 | 6,818 | 5,025 | 5,117 | 5,200 | 4,086 | |
Revenue Growth | 28.64% | 35.68% | -1.80% | -1.60% | 27.26% | 20.39% |
Cost of Revenue | 3,032 | 2,992 | 2,480 | 2,575 | 2,737 | 2,106 |
Gross Profit | 4,338 | 3,826 | 2,545 | 2,542 | 2,463 | 1,980 |
Selling, General & Admin | 3,559 | 3,490 | 2,307 | 2,101 | 2,052 | 1,618 |
Operating Expenses | 3,554 | 3,485 | 2,310 | 2,101 | 2,043 | 1,627 |
Operating Income | 784 | 341 | 235 | 441 | 420 | 353 |
Interest Expense | -10 | - | - | - | - | - |
Interest & Investment Income | 25 | 11 | 15 | 10 | 10 | 10 |
Currency Exchange Gain (Loss) | -5 | -21 | 2 | -13 | 27 | 14 |
Other Non Operating Income (Expenses) | -5 | -10 | -4 | -3 | - | 8 |
EBT Excluding Unusual Items | 789 | 321 | 248 | 435 | 457 | 385 |
Gain (Loss) on Sale of Investments | -31 | - | - | - | - | - |
Asset Writedown | -11 | -46 | - | -8 | - | - |
Pretax Income | 747 | 275 | 248 | 427 | 457 | 385 |
Income Tax Expense | 283 | 114 | 53 | 120 | 101 | 111 |
Earnings From Continuing Operations | 464 | 161 | 195 | 307 | 356 | 274 |
Minority Interest in Earnings | -6 | -6 | -12 | - | - | - |
Net Income | 458 | 155 | 183 | 307 | 356 | 274 |
Net Income to Common | 458 | 155 | 183 | 307 | 356 | 274 |
Net Income Growth | 358.00% | -15.30% | -40.39% | -13.76% | 29.93% | 56.57% |
Shares Outstanding (Basic) | 4 | 4 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 4 | 4 | 2 | 2 | 2 | 2 |
Shares Change | 89.22% | 127.71% | 0.01% | 0.04% | 0.02% | -0.01% |
EPS (Basic) | 103.88 | 41.66 | 112.01 | 188.04 | 218.15 | 167.99 |
EPS (Diluted) | 103.88 | 41.66 | 112.01 | 188.04 | 218.15 | 167.89 |
EPS Growth | 142.04% | -62.80% | -40.43% | -13.80% | 29.94% | 56.44% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 828 | 986 | 236 | 475 | 128 | 472 |
Free Cash Flow Per Share | 187.81 | 265.04 | 144.45 | 290.77 | 78.39 | 289.13 |
Dividend Per Share | 59.520 | 59.520 | 114.840 | 114.840 | 109.140 | 83.970 |
Dividend Growth | -48.17% | -48.17% | 0% | 5.22% | 29.98% | 55.90% |
Gross Margin | 58.86% | 56.12% | 50.65% | 49.68% | 47.37% | 48.46% |
Operating Margin | 10.64% | 5.00% | 4.68% | 8.62% | 8.08% | 8.64% |
Profit Margin | 6.21% | 2.27% | 3.64% | 6.00% | 6.85% | 6.71% |
Free Cash Flow Margin | 11.24% | 14.46% | 4.70% | 9.28% | 2.46% | 11.55% |
EBITDA | 954 | 489 | 339 | 530 | 505 | 421 |
EBITDA Margin | 12.94% | 7.17% | 6.75% | 10.36% | 9.71% | 10.30% |
D&A For EBITDA | 170 | 148 | 104 | 89 | 85 | 68 |
EBIT | 784 | 341 | 235 | 441 | 420 | 353 |
EBIT Margin | 10.64% | 5.00% | 4.68% | 8.62% | 8.08% | 8.64% |
Effective Tax Rate | 37.89% | 41.45% | 21.37% | 28.10% | 22.10% | 28.83% |